Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(chimeric antigen receptor). Showing records 1 – 30 of 49 total matches.

[1] [2]

Search Limiters

Last 2 Years | English Only

▼ Search Limiters


Victoria University of Wellington

1. George, Philip. A Phase 1 Dose Escalation Trial of Third Generation Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed and Refractory B-Cell Non Hodgkin Lymphoma.

Degree: 2020, Victoria University of Wellington

 Anti-CD19 Chimeric Antigen Receptor (CAR) T-cell therapy is shifting the treatment paradigm internationally for selected patients with relapsed and refractory B-cell Non- Hodgkin Lymphoma. Despite… (more)

Subjects/Keywords: Lymphoma; Chimeric Antigen Receptor; Immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

George, P. (2020). A Phase 1 Dose Escalation Trial of Third Generation Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed and Refractory B-Cell Non Hodgkin Lymphoma. (Masters Thesis). Victoria University of Wellington. Retrieved from http://hdl.handle.net/10063/9103

Chicago Manual of Style (16th Edition):

George, Philip. “A Phase 1 Dose Escalation Trial of Third Generation Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed and Refractory B-Cell Non Hodgkin Lymphoma.” 2020. Masters Thesis, Victoria University of Wellington. Accessed March 07, 2021. http://hdl.handle.net/10063/9103.

MLA Handbook (7th Edition):

George, Philip. “A Phase 1 Dose Escalation Trial of Third Generation Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed and Refractory B-Cell Non Hodgkin Lymphoma.” 2020. Web. 07 Mar 2021.

Vancouver:

George P. A Phase 1 Dose Escalation Trial of Third Generation Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed and Refractory B-Cell Non Hodgkin Lymphoma. [Internet] [Masters thesis]. Victoria University of Wellington; 2020. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/10063/9103.

Council of Science Editors:

George P. A Phase 1 Dose Escalation Trial of Third Generation Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed and Refractory B-Cell Non Hodgkin Lymphoma. [Masters Thesis]. Victoria University of Wellington; 2020. Available from: http://hdl.handle.net/10063/9103


Brigham Young University

2. Ollerton, Matthew T. Capacity of Human Immunodeficiency Virus Targeting Chimeric Antigen Receptor T Cells to Eliminate Follicular Dendritic Cells Bearing Human Immunodeficiency Virus Immune Complexes.

Degree: PhD, 2017, Brigham Young University

 An important obstacle to a functional cure for HIV/AIDS is the persistence of viral reservoirs found throughout the body in various cells and tissues. Reservoirs… (more)

Subjects/Keywords: HIV; chimeric antigen receptor; follicular dendritic cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ollerton, M. T. (2017). Capacity of Human Immunodeficiency Virus Targeting Chimeric Antigen Receptor T Cells to Eliminate Follicular Dendritic Cells Bearing Human Immunodeficiency Virus Immune Complexes. (Doctoral Dissertation). Brigham Young University. Retrieved from https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=8240&context=etd

Chicago Manual of Style (16th Edition):

Ollerton, Matthew T. “Capacity of Human Immunodeficiency Virus Targeting Chimeric Antigen Receptor T Cells to Eliminate Follicular Dendritic Cells Bearing Human Immunodeficiency Virus Immune Complexes.” 2017. Doctoral Dissertation, Brigham Young University. Accessed March 07, 2021. https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=8240&context=etd.

MLA Handbook (7th Edition):

Ollerton, Matthew T. “Capacity of Human Immunodeficiency Virus Targeting Chimeric Antigen Receptor T Cells to Eliminate Follicular Dendritic Cells Bearing Human Immunodeficiency Virus Immune Complexes.” 2017. Web. 07 Mar 2021.

Vancouver:

Ollerton MT. Capacity of Human Immunodeficiency Virus Targeting Chimeric Antigen Receptor T Cells to Eliminate Follicular Dendritic Cells Bearing Human Immunodeficiency Virus Immune Complexes. [Internet] [Doctoral dissertation]. Brigham Young University; 2017. [cited 2021 Mar 07]. Available from: https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=8240&context=etd.

Council of Science Editors:

Ollerton MT. Capacity of Human Immunodeficiency Virus Targeting Chimeric Antigen Receptor T Cells to Eliminate Follicular Dendritic Cells Bearing Human Immunodeficiency Virus Immune Complexes. [Doctoral Dissertation]. Brigham Young University; 2017. Available from: https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=8240&context=etd

3. Yong, Carmen. Enhancing adoptive immunotherapy: redirecting immune subsets and metabolic pathways.

Degree: 2017, University of Melbourne

 The adoptive transfer of T cells expressing a chimeric antigen receptor (CAR) as a treatment for cancer has achieved impressive responses in haematological malignancies, but… (more)

Subjects/Keywords: cancer immunotherapy; metabolism; chimeric antigen receptor

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yong, C. (2017). Enhancing adoptive immunotherapy: redirecting immune subsets and metabolic pathways. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/194374

Chicago Manual of Style (16th Edition):

Yong, Carmen. “Enhancing adoptive immunotherapy: redirecting immune subsets and metabolic pathways.” 2017. Doctoral Dissertation, University of Melbourne. Accessed March 07, 2021. http://hdl.handle.net/11343/194374.

MLA Handbook (7th Edition):

Yong, Carmen. “Enhancing adoptive immunotherapy: redirecting immune subsets and metabolic pathways.” 2017. Web. 07 Mar 2021.

Vancouver:

Yong C. Enhancing adoptive immunotherapy: redirecting immune subsets and metabolic pathways. [Internet] [Doctoral dissertation]. University of Melbourne; 2017. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/11343/194374.

Council of Science Editors:

Yong C. Enhancing adoptive immunotherapy: redirecting immune subsets and metabolic pathways. [Doctoral Dissertation]. University of Melbourne; 2017. Available from: http://hdl.handle.net/11343/194374


University of Pennsylvania

4. Klichinsky, Michael. Human Chimeric Antigen Receptor Macrophages For Cancer Immunotherapy.

Degree: 2018, University of Pennsylvania

 Despite recent landmark advances in chimeric antigen receptor (CAR) T cell immunotherapy for the treatment of human cancer, metastatic solid tumors remain an intractable challenge.… (more)

Subjects/Keywords: car macrophage; chimeric antigen receptor; chimeric antigen receptor macrophage; macrophage; Allergy and Immunology; Immunology and Infectious Disease; Medical Immunology; Pharmacology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Klichinsky, M. (2018). Human Chimeric Antigen Receptor Macrophages For Cancer Immunotherapy. (Thesis). University of Pennsylvania. Retrieved from https://repository.upenn.edu/edissertations/3137

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Klichinsky, Michael. “Human Chimeric Antigen Receptor Macrophages For Cancer Immunotherapy.” 2018. Thesis, University of Pennsylvania. Accessed March 07, 2021. https://repository.upenn.edu/edissertations/3137.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Klichinsky, Michael. “Human Chimeric Antigen Receptor Macrophages For Cancer Immunotherapy.” 2018. Web. 07 Mar 2021.

Vancouver:

Klichinsky M. Human Chimeric Antigen Receptor Macrophages For Cancer Immunotherapy. [Internet] [Thesis]. University of Pennsylvania; 2018. [cited 2021 Mar 07]. Available from: https://repository.upenn.edu/edissertations/3137.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Klichinsky M. Human Chimeric Antigen Receptor Macrophages For Cancer Immunotherapy. [Thesis]. University of Pennsylvania; 2018. Available from: https://repository.upenn.edu/edissertations/3137

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


McMaster University

5. Hammill, Joanne. PRE-CLINICAL DEVELOPMENT OF SYNTHETIC RECEPTOR-ENGINEERED T LYMPHOCYTES FOR THE TREATMENT OF CANCER: NOVEL RECEPTORS AND UNDERSTANDING TOXICITY.

Degree: PhD, 2018, McMaster University

Advances in our understanding of the molecular events leading to cancer have facilitated the development of next-generation targeted therapies. Among the most promising new approaches… (more)

Subjects/Keywords: Immunology; Immuno-oncology; Chimeric antigen receptor; CAR-T cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hammill, J. (2018). PRE-CLINICAL DEVELOPMENT OF SYNTHETIC RECEPTOR-ENGINEERED T LYMPHOCYTES FOR THE TREATMENT OF CANCER: NOVEL RECEPTORS AND UNDERSTANDING TOXICITY. (Doctoral Dissertation). McMaster University. Retrieved from http://hdl.handle.net/11375/22904

Chicago Manual of Style (16th Edition):

Hammill, Joanne. “PRE-CLINICAL DEVELOPMENT OF SYNTHETIC RECEPTOR-ENGINEERED T LYMPHOCYTES FOR THE TREATMENT OF CANCER: NOVEL RECEPTORS AND UNDERSTANDING TOXICITY.” 2018. Doctoral Dissertation, McMaster University. Accessed March 07, 2021. http://hdl.handle.net/11375/22904.

MLA Handbook (7th Edition):

Hammill, Joanne. “PRE-CLINICAL DEVELOPMENT OF SYNTHETIC RECEPTOR-ENGINEERED T LYMPHOCYTES FOR THE TREATMENT OF CANCER: NOVEL RECEPTORS AND UNDERSTANDING TOXICITY.” 2018. Web. 07 Mar 2021.

Vancouver:

Hammill J. PRE-CLINICAL DEVELOPMENT OF SYNTHETIC RECEPTOR-ENGINEERED T LYMPHOCYTES FOR THE TREATMENT OF CANCER: NOVEL RECEPTORS AND UNDERSTANDING TOXICITY. [Internet] [Doctoral dissertation]. McMaster University; 2018. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/11375/22904.

Council of Science Editors:

Hammill J. PRE-CLINICAL DEVELOPMENT OF SYNTHETIC RECEPTOR-ENGINEERED T LYMPHOCYTES FOR THE TREATMENT OF CANCER: NOVEL RECEPTORS AND UNDERSTANDING TOXICITY. [Doctoral Dissertation]. McMaster University; 2018. Available from: http://hdl.handle.net/11375/22904


University of California – San Diego

6. Huang, Peng Fei. Immunotherapy Using Chimeric Antigen Receptor Macrophage.

Degree: Biology, 2019, University of California – San Diego

Chimeric antigen receptor (CAR) T cell immunotherapy has become one of the most prominent and leading cancer therapies due to its remarkable success in targeting… (more)

Subjects/Keywords: Biology; Chimeric Antigen Receptor; Immunotherapy; Macrophages; Solid Tumors; Tumor Microenvironment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Huang, P. F. (2019). Immunotherapy Using Chimeric Antigen Receptor Macrophage. (Thesis). University of California – San Diego. Retrieved from http://www.escholarship.org/uc/item/2cx6x7vt

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Huang, Peng Fei. “Immunotherapy Using Chimeric Antigen Receptor Macrophage.” 2019. Thesis, University of California – San Diego. Accessed March 07, 2021. http://www.escholarship.org/uc/item/2cx6x7vt.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Huang, Peng Fei. “Immunotherapy Using Chimeric Antigen Receptor Macrophage.” 2019. Web. 07 Mar 2021.

Vancouver:

Huang PF. Immunotherapy Using Chimeric Antigen Receptor Macrophage. [Internet] [Thesis]. University of California – San Diego; 2019. [cited 2021 Mar 07]. Available from: http://www.escholarship.org/uc/item/2cx6x7vt.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Huang PF. Immunotherapy Using Chimeric Antigen Receptor Macrophage. [Thesis]. University of California – San Diego; 2019. Available from: http://www.escholarship.org/uc/item/2cx6x7vt

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Melbourne

7. DUONG, CONNIE. Generation of novel chimeric antigen receptors to enhance the specificity and activity of T cells for the adoptive immunotherapy for cancer.

Degree: 2014, University of Melbourne

 Adoptive immunotherapy is a promising treatment for cancer, with response rates of up to 70% in metastatic melanoma. To broaden this approach, T cells have… (more)

Subjects/Keywords: adoptive immunotherapy; cancer; T cell; chimeric antigen receptor

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

DUONG, C. (2014). Generation of novel chimeric antigen receptors to enhance the specificity and activity of T cells for the adoptive immunotherapy for cancer. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/44219

Chicago Manual of Style (16th Edition):

DUONG, CONNIE. “Generation of novel chimeric antigen receptors to enhance the specificity and activity of T cells for the adoptive immunotherapy for cancer.” 2014. Doctoral Dissertation, University of Melbourne. Accessed March 07, 2021. http://hdl.handle.net/11343/44219.

MLA Handbook (7th Edition):

DUONG, CONNIE. “Generation of novel chimeric antigen receptors to enhance the specificity and activity of T cells for the adoptive immunotherapy for cancer.” 2014. Web. 07 Mar 2021.

Vancouver:

DUONG C. Generation of novel chimeric antigen receptors to enhance the specificity and activity of T cells for the adoptive immunotherapy for cancer. [Internet] [Doctoral dissertation]. University of Melbourne; 2014. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/11343/44219.

Council of Science Editors:

DUONG C. Generation of novel chimeric antigen receptors to enhance the specificity and activity of T cells for the adoptive immunotherapy for cancer. [Doctoral Dissertation]. University of Melbourne; 2014. Available from: http://hdl.handle.net/11343/44219


University of Melbourne

8. Mills, Jane Kathleen. Combining TIL and CAR for adoptive cell therapy in metastatic melanoma.

Degree: 2019, University of Melbourne

 Background Metastatic melanoma is a highly lethal disease, and until recently patients had limited therapeutic options. Knowledge and understanding of the role the immune system… (more)

Subjects/Keywords: melanoma; metastatic; adoptive cell therapy; ACT; chimeric antigen receptor; CAR; immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mills, J. K. (2019). Combining TIL and CAR for adoptive cell therapy in metastatic melanoma. (Masters Thesis). University of Melbourne. Retrieved from http://hdl.handle.net/11343/228933

Chicago Manual of Style (16th Edition):

Mills, Jane Kathleen. “Combining TIL and CAR for adoptive cell therapy in metastatic melanoma.” 2019. Masters Thesis, University of Melbourne. Accessed March 07, 2021. http://hdl.handle.net/11343/228933.

MLA Handbook (7th Edition):

Mills, Jane Kathleen. “Combining TIL and CAR for adoptive cell therapy in metastatic melanoma.” 2019. Web. 07 Mar 2021.

Vancouver:

Mills JK. Combining TIL and CAR for adoptive cell therapy in metastatic melanoma. [Internet] [Masters thesis]. University of Melbourne; 2019. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/11343/228933.

Council of Science Editors:

Mills JK. Combining TIL and CAR for adoptive cell therapy in metastatic melanoma. [Masters Thesis]. University of Melbourne; 2019. Available from: http://hdl.handle.net/11343/228933


University of Southern California

9. Gong, Songjie. Construction and testing of chimeric antigen receptor targeting CS1 for treatment of primary effusion lymphoma.

Degree: MS, Molecular Microbiology and Immunology, 2015, University of Southern California

 Currently, no effective therapies exist for human Primary effusion Lymphoma (PEL). Here we used a humanized CS1 monoclonal antibody (mAb) to target CS1, which is… (more)

Subjects/Keywords: primary effusion lymphoma; multiple myeloma; chimeric antigen receptor; CS1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gong, S. (2015). Construction and testing of chimeric antigen receptor targeting CS1 for treatment of primary effusion lymphoma. (Masters Thesis). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/615523/rec/1608

Chicago Manual of Style (16th Edition):

Gong, Songjie. “Construction and testing of chimeric antigen receptor targeting CS1 for treatment of primary effusion lymphoma.” 2015. Masters Thesis, University of Southern California. Accessed March 07, 2021. http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/615523/rec/1608.

MLA Handbook (7th Edition):

Gong, Songjie. “Construction and testing of chimeric antigen receptor targeting CS1 for treatment of primary effusion lymphoma.” 2015. Web. 07 Mar 2021.

Vancouver:

Gong S. Construction and testing of chimeric antigen receptor targeting CS1 for treatment of primary effusion lymphoma. [Internet] [Masters thesis]. University of Southern California; 2015. [cited 2021 Mar 07]. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/615523/rec/1608.

Council of Science Editors:

Gong S. Construction and testing of chimeric antigen receptor targeting CS1 for treatment of primary effusion lymphoma. [Masters Thesis]. University of Southern California; 2015. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/615523/rec/1608


University of New South Wales

10. Chaudhry, Kajal. The dynamics of anti-tumour responses generated by chimeric antigen receptor-modified immune effector cells.

Degree: Graduate School of Biomedical Engineering, 2018, University of New South Wales

 A patient’s own T cells can be genetically modified and amplified in the laboratory to target antigens expressed ontumour cells through the introduction of chimeric(more)

Subjects/Keywords: T cells; Adoptive immunotherapy; Chimeric antigen receptor; NK cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chaudhry, K. (2018). The dynamics of anti-tumour responses generated by chimeric antigen receptor-modified immune effector cells. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/61998

Chicago Manual of Style (16th Edition):

Chaudhry, Kajal. “The dynamics of anti-tumour responses generated by chimeric antigen receptor-modified immune effector cells.” 2018. Doctoral Dissertation, University of New South Wales. Accessed March 07, 2021. http://handle.unsw.edu.au/1959.4/61998.

MLA Handbook (7th Edition):

Chaudhry, Kajal. “The dynamics of anti-tumour responses generated by chimeric antigen receptor-modified immune effector cells.” 2018. Web. 07 Mar 2021.

Vancouver:

Chaudhry K. The dynamics of anti-tumour responses generated by chimeric antigen receptor-modified immune effector cells. [Internet] [Doctoral dissertation]. University of New South Wales; 2018. [cited 2021 Mar 07]. Available from: http://handle.unsw.edu.au/1959.4/61998.

Council of Science Editors:

Chaudhry K. The dynamics of anti-tumour responses generated by chimeric antigen receptor-modified immune effector cells. [Doctoral Dissertation]. University of New South Wales; 2018. Available from: http://handle.unsw.edu.au/1959.4/61998


University of Toronto

11. Oldham, Robyn Anne Alexa. Development and Testing of Novel Cancer Immunotherapies for Hematological Malignancies.

Degree: PhD, 2020, University of Toronto

 Cancer immunotherapy – therapies that harness the human immune system to deliver personalized treatments – has become the subject of intensive study as multiple approaches… (more)

Subjects/Keywords: Antibody; Cancer; Chimeric antigen receptor; Immunotherapy; T-Rapa; Tumour-associated antigen; 0992

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Oldham, R. A. A. (2020). Development and Testing of Novel Cancer Immunotherapies for Hematological Malignancies. (Doctoral Dissertation). University of Toronto. Retrieved from http://hdl.handle.net/1807/103328

Chicago Manual of Style (16th Edition):

Oldham, Robyn Anne Alexa. “Development and Testing of Novel Cancer Immunotherapies for Hematological Malignancies.” 2020. Doctoral Dissertation, University of Toronto. Accessed March 07, 2021. http://hdl.handle.net/1807/103328.

MLA Handbook (7th Edition):

Oldham, Robyn Anne Alexa. “Development and Testing of Novel Cancer Immunotherapies for Hematological Malignancies.” 2020. Web. 07 Mar 2021.

Vancouver:

Oldham RAA. Development and Testing of Novel Cancer Immunotherapies for Hematological Malignancies. [Internet] [Doctoral dissertation]. University of Toronto; 2020. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/1807/103328.

Council of Science Editors:

Oldham RAA. Development and Testing of Novel Cancer Immunotherapies for Hematological Malignancies. [Doctoral Dissertation]. University of Toronto; 2020. Available from: http://hdl.handle.net/1807/103328


UCLA

12. Zah, Eugenia. Engineering bispecific chimeric antigen receptors to improve the efficacy of adoptive T-cell therapy.

Degree: Chemical Engineering, 2018, UCLA

 The recent FDA approval of CD19 chimeric antigen receptor (CAR) adoptive T-cell therapy for B-cell leukemias serves to highlight CAR-T cell therapy as a promising… (more)

Subjects/Keywords: Chemical engineering; Immunology; Adoptive T-cell therapy; Cancer immunotherapy; Chimeric antigen receptor

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zah, E. (2018). Engineering bispecific chimeric antigen receptors to improve the efficacy of adoptive T-cell therapy. (Thesis). UCLA. Retrieved from http://www.escholarship.org/uc/item/019427pr

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Zah, Eugenia. “Engineering bispecific chimeric antigen receptors to improve the efficacy of adoptive T-cell therapy.” 2018. Thesis, UCLA. Accessed March 07, 2021. http://www.escholarship.org/uc/item/019427pr.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Zah, Eugenia. “Engineering bispecific chimeric antigen receptors to improve the efficacy of adoptive T-cell therapy.” 2018. Web. 07 Mar 2021.

Vancouver:

Zah E. Engineering bispecific chimeric antigen receptors to improve the efficacy of adoptive T-cell therapy. [Internet] [Thesis]. UCLA; 2018. [cited 2021 Mar 07]. Available from: http://www.escholarship.org/uc/item/019427pr.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Zah E. Engineering bispecific chimeric antigen receptors to improve the efficacy of adoptive T-cell therapy. [Thesis]. UCLA; 2018. Available from: http://www.escholarship.org/uc/item/019427pr

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Debrecen

13. Pham, Huynh Thuy An. Characterization of chimeric antigen receptor (CAR) Modified T Cells specific for P97 and HMW-MAA human melanoma .

Degree: DE – Gyógyszerésztudományi Kar, University of Debrecen

 Anti-p97 and HMW-MAA CAR T cells recognized Melur target cells in vitro. P97 CAR induced faster activation and better cytokine production of T cells, even… (more)

Subjects/Keywords: Chimeric Antigen Receptor; Melanoma; Immunecell Therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pham, H. T. A. (n.d.). Characterization of chimeric antigen receptor (CAR) Modified T Cells specific for P97 and HMW-MAA human melanoma . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/267959

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Pham, Huynh Thuy An. “Characterization of chimeric antigen receptor (CAR) Modified T Cells specific for P97 and HMW-MAA human melanoma .” Thesis, University of Debrecen. Accessed March 07, 2021. http://hdl.handle.net/2437/267959.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Pham, Huynh Thuy An. “Characterization of chimeric antigen receptor (CAR) Modified T Cells specific for P97 and HMW-MAA human melanoma .” Web. 07 Mar 2021.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Pham HTA. Characterization of chimeric antigen receptor (CAR) Modified T Cells specific for P97 and HMW-MAA human melanoma . [Internet] [Thesis]. University of Debrecen; [cited 2021 Mar 07]. Available from: http://hdl.handle.net/2437/267959.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Pham HTA. Characterization of chimeric antigen receptor (CAR) Modified T Cells specific for P97 and HMW-MAA human melanoma . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/267959

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


University of Melbourne

14. Davenport, Alexander. Investigating the functional biology of chimeric antigen receptor T cells.

Degree: 2017, University of Melbourne

 Despite the success of autologous chimeric antigen receptor (CAR) T cells to treat patients with refractory B cell acute lymphoblastic leukaemia, (ALL) and lymphoma, there… (more)

Subjects/Keywords: immunology; cancer immunology; immunotherapy; cancer; CAR; chimeric antigen receptor; T cell; CAR T cell

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Davenport, A. (2017). Investigating the functional biology of chimeric antigen receptor T cells. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/137338

Chicago Manual of Style (16th Edition):

Davenport, Alexander. “Investigating the functional biology of chimeric antigen receptor T cells.” 2017. Doctoral Dissertation, University of Melbourne. Accessed March 07, 2021. http://hdl.handle.net/11343/137338.

MLA Handbook (7th Edition):

Davenport, Alexander. “Investigating the functional biology of chimeric antigen receptor T cells.” 2017. Web. 07 Mar 2021.

Vancouver:

Davenport A. Investigating the functional biology of chimeric antigen receptor T cells. [Internet] [Doctoral dissertation]. University of Melbourne; 2017. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/11343/137338.

Council of Science Editors:

Davenport A. Investigating the functional biology of chimeric antigen receptor T cells. [Doctoral Dissertation]. University of Melbourne; 2017. Available from: http://hdl.handle.net/11343/137338


Duke University

15. Lin, Regina. Targeting T Cells for the Immune-Modulation of Human Diseases .

Degree: 2015, Duke University

  Dysregulated inflammation underlies the pathogenesis of a myriad of human diseases ranging from cancer to autoimmunity. As coordinators, executers and sentinels of host immunity,… (more)

Subjects/Keywords: Immunology; Adoptive T cell transfer; Autoimmune diseases; Chimeric antigen receptor; Immunotherapy; microRNA

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lin, R. (2015). Targeting T Cells for the Immune-Modulation of Human Diseases . (Thesis). Duke University. Retrieved from http://hdl.handle.net/10161/9824

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lin, Regina. “Targeting T Cells for the Immune-Modulation of Human Diseases .” 2015. Thesis, Duke University. Accessed March 07, 2021. http://hdl.handle.net/10161/9824.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lin, Regina. “Targeting T Cells for the Immune-Modulation of Human Diseases .” 2015. Web. 07 Mar 2021.

Vancouver:

Lin R. Targeting T Cells for the Immune-Modulation of Human Diseases . [Internet] [Thesis]. Duke University; 2015. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/10161/9824.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lin R. Targeting T Cells for the Immune-Modulation of Human Diseases . [Thesis]. Duke University; 2015. Available from: http://hdl.handle.net/10161/9824

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Pennsylvania

16. Santoro, Stephen. T Cells Bearing a Chimeric Antigen Receptor Against the Tumor Vasculature Destroy the Tumor Endothelium and Result in Tumor Regression.

Degree: 2014, University of Pennsylvania

 Aberrant blood vessels enable tumor growth, provide a barrier to immune infiltration, and serve as a source of pro-tumorigenic signals. Targeting tumor blood vessels for… (more)

Subjects/Keywords: Adoptive therapy; Chimeric antigen receptor; Endothelial cells; Prostate-specific membrane antigen; Vascular disruption; Biology; Cell Biology; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Santoro, S. (2014). T Cells Bearing a Chimeric Antigen Receptor Against the Tumor Vasculature Destroy the Tumor Endothelium and Result in Tumor Regression. (Thesis). University of Pennsylvania. Retrieved from https://repository.upenn.edu/edissertations/1432

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Santoro, Stephen. “T Cells Bearing a Chimeric Antigen Receptor Against the Tumor Vasculature Destroy the Tumor Endothelium and Result in Tumor Regression.” 2014. Thesis, University of Pennsylvania. Accessed March 07, 2021. https://repository.upenn.edu/edissertations/1432.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Santoro, Stephen. “T Cells Bearing a Chimeric Antigen Receptor Against the Tumor Vasculature Destroy the Tumor Endothelium and Result in Tumor Regression.” 2014. Web. 07 Mar 2021.

Vancouver:

Santoro S. T Cells Bearing a Chimeric Antigen Receptor Against the Tumor Vasculature Destroy the Tumor Endothelium and Result in Tumor Regression. [Internet] [Thesis]. University of Pennsylvania; 2014. [cited 2021 Mar 07]. Available from: https://repository.upenn.edu/edissertations/1432.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Santoro S. T Cells Bearing a Chimeric Antigen Receptor Against the Tumor Vasculature Destroy the Tumor Endothelium and Result in Tumor Regression. [Thesis]. University of Pennsylvania; 2014. Available from: https://repository.upenn.edu/edissertations/1432

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Boston University

17. Pedro, Kyle D. Cell-to-cell transmission and intrinsic mechanisms that influence human immunodeficiency virus infection.

Degree: PhD, Microbiology, 2020, Boston University

 Early in the course of human immunodeficiency virus (HIV) infection a population of latently infected cells is established which persists despite long-term anti-retroviral treatment. This… (more)

Subjects/Keywords: Microbiology; CD4+ T cell; Chimeric antigen receptor; Dendritic cell; HIV latency; HIV transcription; T cell receptor signaling

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pedro, K. D. (2020). Cell-to-cell transmission and intrinsic mechanisms that influence human immunodeficiency virus infection. (Doctoral Dissertation). Boston University. Retrieved from http://hdl.handle.net/2144/42067

Chicago Manual of Style (16th Edition):

Pedro, Kyle D. “Cell-to-cell transmission and intrinsic mechanisms that influence human immunodeficiency virus infection.” 2020. Doctoral Dissertation, Boston University. Accessed March 07, 2021. http://hdl.handle.net/2144/42067.

MLA Handbook (7th Edition):

Pedro, Kyle D. “Cell-to-cell transmission and intrinsic mechanisms that influence human immunodeficiency virus infection.” 2020. Web. 07 Mar 2021.

Vancouver:

Pedro KD. Cell-to-cell transmission and intrinsic mechanisms that influence human immunodeficiency virus infection. [Internet] [Doctoral dissertation]. Boston University; 2020. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/2144/42067.

Council of Science Editors:

Pedro KD. Cell-to-cell transmission and intrinsic mechanisms that influence human immunodeficiency virus infection. [Doctoral Dissertation]. Boston University; 2020. Available from: http://hdl.handle.net/2144/42067


UCLA

18. Lorenzini, Michael Hideo. Engineering Robust T-Cell Response Against Immunosuppressive Tumors.

Degree: Bioengineering, 2016, UCLA

 With the establishment of clinically effective adoptive T-cell therapy for metastatic cancer, efforts are growing to advance T-cell therapy for new indications, especially solid tumors.… (more)

Subjects/Keywords: Immunology; Biomedical engineering; Molecular biology; Adoptive cell therapy; Cancer immunosuppression; Cancer immunotherapy; CAR-T cells; Chimeric antigen receptor; TGF beta

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lorenzini, M. H. (2016). Engineering Robust T-Cell Response Against Immunosuppressive Tumors. (Thesis). UCLA. Retrieved from http://www.escholarship.org/uc/item/26h6c920

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lorenzini, Michael Hideo. “Engineering Robust T-Cell Response Against Immunosuppressive Tumors.” 2016. Thesis, UCLA. Accessed March 07, 2021. http://www.escholarship.org/uc/item/26h6c920.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lorenzini, Michael Hideo. “Engineering Robust T-Cell Response Against Immunosuppressive Tumors.” 2016. Web. 07 Mar 2021.

Vancouver:

Lorenzini MH. Engineering Robust T-Cell Response Against Immunosuppressive Tumors. [Internet] [Thesis]. UCLA; 2016. [cited 2021 Mar 07]. Available from: http://www.escholarship.org/uc/item/26h6c920.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lorenzini MH. Engineering Robust T-Cell Response Against Immunosuppressive Tumors. [Thesis]. UCLA; 2016. Available from: http://www.escholarship.org/uc/item/26h6c920

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


UCLA

19. Chang, ZeNan Li. Rewiring signaling responses to soluble extracellular cues for T-cell therapies and beyond.

Degree: Molecular Biology, 2017, UCLA

 Soluble extracellular factors are a commonly used medium of communication between a cell and its environment. The ability to program the response of cell-based therapies… (more)

Subjects/Keywords: Molecular biology; Immunology; Chemical engineering; chimeric antigen receptor; immunotherapy; protein engineering; synthetic biology; T-cell therapy; TGF-β

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chang, Z. L. (2017). Rewiring signaling responses to soluble extracellular cues for T-cell therapies and beyond. (Thesis). UCLA. Retrieved from http://www.escholarship.org/uc/item/1gg9s6gk

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Chang, ZeNan Li. “Rewiring signaling responses to soluble extracellular cues for T-cell therapies and beyond.” 2017. Thesis, UCLA. Accessed March 07, 2021. http://www.escholarship.org/uc/item/1gg9s6gk.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Chang, ZeNan Li. “Rewiring signaling responses to soluble extracellular cues for T-cell therapies and beyond.” 2017. Web. 07 Mar 2021.

Vancouver:

Chang ZL. Rewiring signaling responses to soluble extracellular cues for T-cell therapies and beyond. [Internet] [Thesis]. UCLA; 2017. [cited 2021 Mar 07]. Available from: http://www.escholarship.org/uc/item/1gg9s6gk.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Chang ZL. Rewiring signaling responses to soluble extracellular cues for T-cell therapies and beyond. [Thesis]. UCLA; 2017. Available from: http://www.escholarship.org/uc/item/1gg9s6gk

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of California – San Diego

20. Allen, Molly Elizabeth. Using Light to Improve CAR T Cell Immunotherapy Development and Applications.

Degree: Bioengineering, 2019, University of California – San Diego

 Cancer is the second-leading cause of death worldwide. Over the past two decades, chimeric antigen receptor (CAR) T cell therapy has emerged as a promising… (more)

Subjects/Keywords: Bioengineering; Molecular biology; Biomedical engineering; Biosensor; Chimeric Antigen Receptor (CAR); Immunotherapy; Optogenetics; Synthetic Biology; T cell

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Allen, M. E. (2019). Using Light to Improve CAR T Cell Immunotherapy Development and Applications. (Thesis). University of California – San Diego. Retrieved from http://www.escholarship.org/uc/item/8bk4w5hc

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Allen, Molly Elizabeth. “Using Light to Improve CAR T Cell Immunotherapy Development and Applications.” 2019. Thesis, University of California – San Diego. Accessed March 07, 2021. http://www.escholarship.org/uc/item/8bk4w5hc.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Allen, Molly Elizabeth. “Using Light to Improve CAR T Cell Immunotherapy Development and Applications.” 2019. Web. 07 Mar 2021.

Vancouver:

Allen ME. Using Light to Improve CAR T Cell Immunotherapy Development and Applications. [Internet] [Thesis]. University of California – San Diego; 2019. [cited 2021 Mar 07]. Available from: http://www.escholarship.org/uc/item/8bk4w5hc.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Allen ME. Using Light to Improve CAR T Cell Immunotherapy Development and Applications. [Thesis]. University of California – San Diego; 2019. Available from: http://www.escholarship.org/uc/item/8bk4w5hc

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

21. Jespersen, Henrik. Translational studies of metastatic melanoma in the era of immunotherapy - from humanized mouse models to clinical trials.

Degree: 2020, University of Gothenburg / Göteborgs Universitet

 Immunotherapy with PD-1 inhibitors has transformed the treatment of met-astatic cutaneous mela- noma, and can lead to complete and durable responses in a proportion of… (more)

Subjects/Keywords: Metastatic melanoma; Uveal melanoma; Humanized mouse models; Immunotherapy; Chimeric antigen receptor T cells; PD-1 inhibition; Epigenetics; Histone deacetylase inhibition

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jespersen, H. (2020). Translational studies of metastatic melanoma in the era of immunotherapy - from humanized mouse models to clinical trials. (Thesis). University of Gothenburg / Göteborgs Universitet. Retrieved from http://hdl.handle.net/2077/62684

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Jespersen, Henrik. “Translational studies of metastatic melanoma in the era of immunotherapy - from humanized mouse models to clinical trials.” 2020. Thesis, University of Gothenburg / Göteborgs Universitet. Accessed March 07, 2021. http://hdl.handle.net/2077/62684.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Jespersen, Henrik. “Translational studies of metastatic melanoma in the era of immunotherapy - from humanized mouse models to clinical trials.” 2020. Web. 07 Mar 2021.

Vancouver:

Jespersen H. Translational studies of metastatic melanoma in the era of immunotherapy - from humanized mouse models to clinical trials. [Internet] [Thesis]. University of Gothenburg / Göteborgs Universitet; 2020. [cited 2021 Mar 07]. Available from: http://hdl.handle.net/2077/62684.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Jespersen H. Translational studies of metastatic melanoma in the era of immunotherapy - from humanized mouse models to clinical trials. [Thesis]. University of Gothenburg / Göteborgs Universitet; 2020. Available from: http://hdl.handle.net/2077/62684

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

22. Ollerton, Matthew T. Capacity of Human Immunodeficiency Virus Targeting Chimeric Antigen Receptor T Cells to Eliminate Follicular Dendritic Cells Bearing Human Immunodeficiency Virus Immune Complexes.

Degree: PhD, 2017, Brigham Young University

 An important obstacle to a functional cure for HIV/AIDS is the persistence of viral reservoirs found throughout the body in various cells and tissues. Reservoirs… (more)

Subjects/Keywords: HIV; chimeric antigen receptor; follicular dendritic cells

…presenting cell BCMA B cell maturation antigen CAR Chimeric antigen receptor CCR5 C-C motif… …1.3 Chimeric Antigen Receptor T cells Chimeric Antigen Receptor T (CAR-T) cells… …trapping on FDCs. Although CD32 is considered a low-affinity receptor for antigen binding, FDCs… …design of chimeric antigen receptors (CARs) on lymphocytes capable of cytoxicity… …antigen. This was accomplished by replacing the variable region of the T cell 19 receptor… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ollerton, M. T. (2017). Capacity of Human Immunodeficiency Virus Targeting Chimeric Antigen Receptor T Cells to Eliminate Follicular Dendritic Cells Bearing Human Immunodeficiency Virus Immune Complexes. (Doctoral Dissertation). Brigham Young University. Retrieved from https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=8292&context=etd

Chicago Manual of Style (16th Edition):

Ollerton, Matthew T. “Capacity of Human Immunodeficiency Virus Targeting Chimeric Antigen Receptor T Cells to Eliminate Follicular Dendritic Cells Bearing Human Immunodeficiency Virus Immune Complexes.” 2017. Doctoral Dissertation, Brigham Young University. Accessed March 07, 2021. https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=8292&context=etd.

MLA Handbook (7th Edition):

Ollerton, Matthew T. “Capacity of Human Immunodeficiency Virus Targeting Chimeric Antigen Receptor T Cells to Eliminate Follicular Dendritic Cells Bearing Human Immunodeficiency Virus Immune Complexes.” 2017. Web. 07 Mar 2021.

Vancouver:

Ollerton MT. Capacity of Human Immunodeficiency Virus Targeting Chimeric Antigen Receptor T Cells to Eliminate Follicular Dendritic Cells Bearing Human Immunodeficiency Virus Immune Complexes. [Internet] [Doctoral dissertation]. Brigham Young University; 2017. [cited 2021 Mar 07]. Available from: https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=8292&context=etd.

Council of Science Editors:

Ollerton MT. Capacity of Human Immunodeficiency Virus Targeting Chimeric Antigen Receptor T Cells to Eliminate Follicular Dendritic Cells Bearing Human Immunodeficiency Virus Immune Complexes. [Doctoral Dissertation]. Brigham Young University; 2017. Available from: https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=8292&context=etd

23. Yong, Carmen. Enhancing adoptive immunotherapy : redirecting immune subsets and metabolic pathways : Optimisation des immunothérapies : manipulation de sous populations immunitaires et exploitation du métabolisme.

Degree: Docteur es, Biologie Santé, 2017, Montpellier; University of Melbourne. The Sir Peter MacCallum Department of Oncology

 Le transfert adoptif de cellules T exprimant un récepteur chimérique reconnaissant un antigène (CAR), est un traitement qui génère des réponses impressionnantes dans les cancers… (more)

Subjects/Keywords: Immunothérapie; Cellules T; Differenciation; Anti-Tumoral; Récepteur chimérique; Metabolisme; Immunotherapy; T cells; Differentiation; Anti-Tumor; Chimeric antigen receptor; Metabolism

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yong, C. (2017). Enhancing adoptive immunotherapy : redirecting immune subsets and metabolic pathways : Optimisation des immunothérapies : manipulation de sous populations immunitaires et exploitation du métabolisme. (Doctoral Dissertation). Montpellier; University of Melbourne. The Sir Peter MacCallum Department of Oncology. Retrieved from http://www.theses.fr/2017MONTT059

Chicago Manual of Style (16th Edition):

Yong, Carmen. “Enhancing adoptive immunotherapy : redirecting immune subsets and metabolic pathways : Optimisation des immunothérapies : manipulation de sous populations immunitaires et exploitation du métabolisme.” 2017. Doctoral Dissertation, Montpellier; University of Melbourne. The Sir Peter MacCallum Department of Oncology. Accessed March 07, 2021. http://www.theses.fr/2017MONTT059.

MLA Handbook (7th Edition):

Yong, Carmen. “Enhancing adoptive immunotherapy : redirecting immune subsets and metabolic pathways : Optimisation des immunothérapies : manipulation de sous populations immunitaires et exploitation du métabolisme.” 2017. Web. 07 Mar 2021.

Vancouver:

Yong C. Enhancing adoptive immunotherapy : redirecting immune subsets and metabolic pathways : Optimisation des immunothérapies : manipulation de sous populations immunitaires et exploitation du métabolisme. [Internet] [Doctoral dissertation]. Montpellier; University of Melbourne. The Sir Peter MacCallum Department of Oncology; 2017. [cited 2021 Mar 07]. Available from: http://www.theses.fr/2017MONTT059.

Council of Science Editors:

Yong C. Enhancing adoptive immunotherapy : redirecting immune subsets and metabolic pathways : Optimisation des immunothérapies : manipulation de sous populations immunitaires et exploitation du métabolisme. [Doctoral Dissertation]. Montpellier; University of Melbourne. The Sir Peter MacCallum Department of Oncology; 2017. Available from: http://www.theses.fr/2017MONTT059


University of Pennsylvania

24. Kawalekar, Omkar Uday. Car Drivers and Fuel Sources: How Distinct Signaling Domains in Chimeric Antigen Receptors Reprogram T Cells.

Degree: 2016, University of Pennsylvania

 With breakthroughs in synthetic biology, improved cell culture techniques and advanced genetic engineering, it has now become possible to generate bi-specific primary human T cells… (more)

Subjects/Keywords: Chimeric Antigen Receptor; Immunotherapy; Metabolism; T cells; Allergy and Immunology; Cell Biology; Immunology and Infectious Disease; Medical Immunology; Molecular Biology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kawalekar, O. U. (2016). Car Drivers and Fuel Sources: How Distinct Signaling Domains in Chimeric Antigen Receptors Reprogram T Cells. (Thesis). University of Pennsylvania. Retrieved from https://repository.upenn.edu/edissertations/1804

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kawalekar, Omkar Uday. “Car Drivers and Fuel Sources: How Distinct Signaling Domains in Chimeric Antigen Receptors Reprogram T Cells.” 2016. Thesis, University of Pennsylvania. Accessed March 07, 2021. https://repository.upenn.edu/edissertations/1804.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kawalekar, Omkar Uday. “Car Drivers and Fuel Sources: How Distinct Signaling Domains in Chimeric Antigen Receptors Reprogram T Cells.” 2016. Web. 07 Mar 2021.

Vancouver:

Kawalekar OU. Car Drivers and Fuel Sources: How Distinct Signaling Domains in Chimeric Antigen Receptors Reprogram T Cells. [Internet] [Thesis]. University of Pennsylvania; 2016. [cited 2021 Mar 07]. Available from: https://repository.upenn.edu/edissertations/1804.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kawalekar OU. Car Drivers and Fuel Sources: How Distinct Signaling Domains in Chimeric Antigen Receptors Reprogram T Cells. [Thesis]. University of Pennsylvania; 2016. Available from: https://repository.upenn.edu/edissertations/1804

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Pennsylvania

25. Lo, Albert. Finding Common Ground to Treat Primary and Metastatic Cancer: The Potential of Targeting Tumor Stroma.

Degree: 2016, University of Pennsylvania

 Primary carcinomas and metastases are complex organ-like structures composed of malignant parenchymal epithelial tissues and a desmoplastic stroma formed by accumulation of hematopoietic cells, mesenchymal… (more)

Subjects/Keywords: Cancer-associated fibroblasts (CAFs); Chimeric antigen receptor (CAR) T cells; Fibroblast activation protein (FAP); Tumor microenvironment; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lo, A. (2016). Finding Common Ground to Treat Primary and Metastatic Cancer: The Potential of Targeting Tumor Stroma. (Thesis). University of Pennsylvania. Retrieved from https://repository.upenn.edu/edissertations/1862

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lo, Albert. “Finding Common Ground to Treat Primary and Metastatic Cancer: The Potential of Targeting Tumor Stroma.” 2016. Thesis, University of Pennsylvania. Accessed March 07, 2021. https://repository.upenn.edu/edissertations/1862.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lo, Albert. “Finding Common Ground to Treat Primary and Metastatic Cancer: The Potential of Targeting Tumor Stroma.” 2016. Web. 07 Mar 2021.

Vancouver:

Lo A. Finding Common Ground to Treat Primary and Metastatic Cancer: The Potential of Targeting Tumor Stroma. [Internet] [Thesis]. University of Pennsylvania; 2016. [cited 2021 Mar 07]. Available from: https://repository.upenn.edu/edissertations/1862.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lo A. Finding Common Ground to Treat Primary and Metastatic Cancer: The Potential of Targeting Tumor Stroma. [Thesis]. University of Pennsylvania; 2016. Available from: https://repository.upenn.edu/edissertations/1862

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Pennsylvania

26. Panjwani, Mohammed Kazim. Development Of Canine Chimeric Antigen Receptor T Cell Therapy For Treatment & Translation.

Degree: 2017, University of Pennsylvania

Chimeric antigen receptor (CAR) T cell therapy has had remarkable success targeting B cell leukemias in human patients, but unexpected toxicities and failures in other… (more)

Subjects/Keywords: chimeric antigen receptor; comparative oncology; immunotherapy; pre-clinical animal model; Allergy and Immunology; Immunology and Infectious Disease; Medical Immunology; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Panjwani, M. K. (2017). Development Of Canine Chimeric Antigen Receptor T Cell Therapy For Treatment & Translation. (Thesis). University of Pennsylvania. Retrieved from https://repository.upenn.edu/edissertations/2513

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Panjwani, Mohammed Kazim. “Development Of Canine Chimeric Antigen Receptor T Cell Therapy For Treatment & Translation.” 2017. Thesis, University of Pennsylvania. Accessed March 07, 2021. https://repository.upenn.edu/edissertations/2513.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Panjwani, Mohammed Kazim. “Development Of Canine Chimeric Antigen Receptor T Cell Therapy For Treatment & Translation.” 2017. Web. 07 Mar 2021.

Vancouver:

Panjwani MK. Development Of Canine Chimeric Antigen Receptor T Cell Therapy For Treatment & Translation. [Internet] [Thesis]. University of Pennsylvania; 2017. [cited 2021 Mar 07]. Available from: https://repository.upenn.edu/edissertations/2513.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Panjwani MK. Development Of Canine Chimeric Antigen Receptor T Cell Therapy For Treatment & Translation. [Thesis]. University of Pennsylvania; 2017. Available from: https://repository.upenn.edu/edissertations/2513

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Pennsylvania

27. Minutolo, Nicholas G. Developing The Next Generation Of Universal Immune Receptors.

Degree: 2019, University of Pennsylvania

Chimeric antigen receptor (CAR) T cell therapy has produced impressive clinical results in the treatment of human cancers; however, their broad use is limited due… (more)

Subjects/Keywords: Adoptive T cell Therapy; Chimeric Antigen Receptor; Immunotherapy; Universal Immune Receptor; Allergy and Immunology; Biology; Immunology and Infectious Disease; Medical Immunology; Pharmacology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Minutolo, N. G. (2019). Developing The Next Generation Of Universal Immune Receptors. (Thesis). University of Pennsylvania. Retrieved from https://repository.upenn.edu/edissertations/3605

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Minutolo, Nicholas G. “Developing The Next Generation Of Universal Immune Receptors.” 2019. Thesis, University of Pennsylvania. Accessed March 07, 2021. https://repository.upenn.edu/edissertations/3605.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Minutolo, Nicholas G. “Developing The Next Generation Of Universal Immune Receptors.” 2019. Web. 07 Mar 2021.

Vancouver:

Minutolo NG. Developing The Next Generation Of Universal Immune Receptors. [Internet] [Thesis]. University of Pennsylvania; 2019. [cited 2021 Mar 07]. Available from: https://repository.upenn.edu/edissertations/3605.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Minutolo NG. Developing The Next Generation Of Universal Immune Receptors. [Thesis]. University of Pennsylvania; 2019. Available from: https://repository.upenn.edu/edissertations/3605

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

28. NATASHA VINANICA. IMPROVING THE EFFICACY OF CHIMERIC ANTIGEN RECEPTOR-T CELLS FOR CANCER THERAPY.

Degree: 2020, National University of Singapore

Subjects/Keywords: chimeric antigen receptor; erythropoietin receptor; erythropoietin; IL-2; T cells; leukemia

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

VINANICA, N. (2020). IMPROVING THE EFFICACY OF CHIMERIC ANTIGEN RECEPTOR-T CELLS FOR CANCER THERAPY. (Thesis). National University of Singapore. Retrieved from https://scholarbank.nus.edu.sg/handle/10635/169796

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

VINANICA, NATASHA. “IMPROVING THE EFFICACY OF CHIMERIC ANTIGEN RECEPTOR-T CELLS FOR CANCER THERAPY.” 2020. Thesis, National University of Singapore. Accessed March 07, 2021. https://scholarbank.nus.edu.sg/handle/10635/169796.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

VINANICA, NATASHA. “IMPROVING THE EFFICACY OF CHIMERIC ANTIGEN RECEPTOR-T CELLS FOR CANCER THERAPY.” 2020. Web. 07 Mar 2021.

Vancouver:

VINANICA N. IMPROVING THE EFFICACY OF CHIMERIC ANTIGEN RECEPTOR-T CELLS FOR CANCER THERAPY. [Internet] [Thesis]. National University of Singapore; 2020. [cited 2021 Mar 07]. Available from: https://scholarbank.nus.edu.sg/handle/10635/169796.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

VINANICA N. IMPROVING THE EFFICACY OF CHIMERIC ANTIGEN RECEPTOR-T CELLS FOR CANCER THERAPY. [Thesis]. National University of Singapore; 2020. Available from: https://scholarbank.nus.edu.sg/handle/10635/169796

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Texas Medical Center

29. Hurton, Lenka. TETHERED IL-15 TO AUGMENT THE THERAPEUTIC POTENTIAL OF T CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTOR: MAINTAINING MEMORY POTENTIAL, PERSISTENCE, AND ANTITUMOR ACTIVITY.

Degree: PhD, 2014, Texas Medical Center

  Tethered IL-15 to augment the therapeutic potential of T cells expressing chimeric antigen receptor: Maintaining memory potential, persistence, and antitumor activity Adoptive immunotherapy can… (more)

Subjects/Keywords: immunotherapy; cytokines; IL-15; chimeric antigen receptor; T-cell persistence; memory; memory stem cell; leukemia; B-ALL; Medical Biotechnology; Medical Immunology; Medicine and Health Sciences; Other Immunology and Infectious Disease

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hurton, L. (2014). TETHERED IL-15 TO AUGMENT THE THERAPEUTIC POTENTIAL OF T CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTOR: MAINTAINING MEMORY POTENTIAL, PERSISTENCE, AND ANTITUMOR ACTIVITY. (Doctoral Dissertation). Texas Medical Center. Retrieved from https://digitalcommons.library.tmc.edu/utgsbs_dissertations/421

Chicago Manual of Style (16th Edition):

Hurton, Lenka. “TETHERED IL-15 TO AUGMENT THE THERAPEUTIC POTENTIAL OF T CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTOR: MAINTAINING MEMORY POTENTIAL, PERSISTENCE, AND ANTITUMOR ACTIVITY.” 2014. Doctoral Dissertation, Texas Medical Center. Accessed March 07, 2021. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/421.

MLA Handbook (7th Edition):

Hurton, Lenka. “TETHERED IL-15 TO AUGMENT THE THERAPEUTIC POTENTIAL OF T CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTOR: MAINTAINING MEMORY POTENTIAL, PERSISTENCE, AND ANTITUMOR ACTIVITY.” 2014. Web. 07 Mar 2021.

Vancouver:

Hurton L. TETHERED IL-15 TO AUGMENT THE THERAPEUTIC POTENTIAL OF T CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTOR: MAINTAINING MEMORY POTENTIAL, PERSISTENCE, AND ANTITUMOR ACTIVITY. [Internet] [Doctoral dissertation]. Texas Medical Center; 2014. [cited 2021 Mar 07]. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/421.

Council of Science Editors:

Hurton L. TETHERED IL-15 TO AUGMENT THE THERAPEUTIC POTENTIAL OF T CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTOR: MAINTAINING MEMORY POTENTIAL, PERSISTENCE, AND ANTITUMOR ACTIVITY. [Doctoral Dissertation]. Texas Medical Center; 2014. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/421


Texas Medical Center

30. Crossland, Denise L. CD56-SPECIFIC T CELLS: USING GENETICALLY ENGINEERED T CELLS TO REDIRECT SPECIFICITY TO A T CELL EXPRESSED ANTIGEN.

Degree: PhD, 2014, Texas Medical Center

  The CD56 antigen is expressed on several deadly malignancies currently lacking long-term efficacious therapies. Chimeric antigen receptor (CAR) based immunotherapies have shown both safety… (more)

Subjects/Keywords: Chimeric Antigen Receptor; CAR; Neural Cell Adhesion Molecule; NCAM; CD56; Fratricide; Autolysis; T cell immunotherapy; self-targeting; CD56CAR; Cancer Biology; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Crossland, D. L. (2014). CD56-SPECIFIC T CELLS: USING GENETICALLY ENGINEERED T CELLS TO REDIRECT SPECIFICITY TO A T CELL EXPRESSED ANTIGEN. (Doctoral Dissertation). Texas Medical Center. Retrieved from https://digitalcommons.library.tmc.edu/utgsbs_dissertations/493

Chicago Manual of Style (16th Edition):

Crossland, Denise L. “CD56-SPECIFIC T CELLS: USING GENETICALLY ENGINEERED T CELLS TO REDIRECT SPECIFICITY TO A T CELL EXPRESSED ANTIGEN.” 2014. Doctoral Dissertation, Texas Medical Center. Accessed March 07, 2021. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/493.

MLA Handbook (7th Edition):

Crossland, Denise L. “CD56-SPECIFIC T CELLS: USING GENETICALLY ENGINEERED T CELLS TO REDIRECT SPECIFICITY TO A T CELL EXPRESSED ANTIGEN.” 2014. Web. 07 Mar 2021.

Vancouver:

Crossland DL. CD56-SPECIFIC T CELLS: USING GENETICALLY ENGINEERED T CELLS TO REDIRECT SPECIFICITY TO A T CELL EXPRESSED ANTIGEN. [Internet] [Doctoral dissertation]. Texas Medical Center; 2014. [cited 2021 Mar 07]. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/493.

Council of Science Editors:

Crossland DL. CD56-SPECIFIC T CELLS: USING GENETICALLY ENGINEERED T CELLS TO REDIRECT SPECIFICITY TO A T CELL EXPRESSED ANTIGEN. [Doctoral Dissertation]. Texas Medical Center; 2014. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/493

[1] [2]

.